How much can biomarkers explain sociodemographic inequalities in cognitive dysfunction and cognitive impairment? Results from a machine learning model in the Health and Retirement Study
Restricted accessResearch articleFirst published online July, 2025
How much can biomarkers explain sociodemographic inequalities in cognitive dysfunction and cognitive impairment? Results from a machine learning model in the Health and Retirement Study
Biomarkers may be pathways by which social adversity affects cognitive aging and Alzheimer's disease and related dementias (ADRD) risk.
Objective
How much variance in cognitive dysfunction and cognitive impairment onset do blood-based and physiological biomarkers provide above and beyond easily attainable sociodemographic variables, and how much can biomarkers explain differences in cognitive functioning and ADRD by sociodemographic variables?
Methods
We utilize machine learning to generate measures of predicted cognitive dysfunction and cognitive impairment incidence based on 91 biomarkers, identify the relative importance of each biomarker, and examine how much these biomarkers mediate sociodemographic differences.
Results
Markers related to cellular aging, neurodegeneration, diet and nutrition, immune functioning, and lung function were identified as important. Biomarkers mediated 47.2–77.3% of the variance associated with age, 22.7–35.2% of racial/ethnic differences in cognitive dysfunction, and 12.5–17.6% of educational differences.
Conclusions
Biomarkers provide the potential to understand pathways linking sociodemographic characteristics to cognitive functioning and health. Future research should consider additional biomarkers and evaluate the specific systems that put people at risk for cognitive impairment.
HebertLEScherrPAMcCannJJ, et al.Is the risk of developing Alzheimer’s disease greater for women than for men?Am J Epidemiol2001; 153: 132–136.
4.
Vila-CastelarCUdeh-MomohCAggarwalNT, et al.Sex and gender considerations in dementia: a call for global research. Nat Aging2023; 3: 463–465.
5.
MielkeMMFerrettiMTIulitaMF, et al.Sex and gender in Alzheimer’s disease – does it matter?Alzheimers Dement2018; 14: 1101–1103.
6.
ManlyJJJonesRNLangaKM, et al.Estimating the prevalence of dementia and mild cognitive impairment in the US: the 2016 health and retirement study harmonized cognitive assessment protocol project. JAMA Neurol2022; 79: 1242–1249.
7.
KornblithEBahorikABoscardinWJ, et al.Association of race and ethnicity with incidence of dementia among older adults. JAMA2022; 327: 1488–1495.
8.
FarinaMPHaywardMDKimJK, et al.Racial and educational disparities in dementia and dementia-free life expectancy. J Gerontol B Psychol Sci Soc Sci2020; 75: e105–e112.
9.
HaywardMDFarinaMPZhangYS, et al.The importance of improving educational attainment for dementia prevalence trends from 2000 to 2014, among older non-Hispanic Black and white Americans. J Gerontol B Psychol Sci Soc Sci2021; 76: 1870–1879.
10.
CrimminsEMSaitoYKimJK, et al.Educational differences in the prevalence of dementia and life expectancy with dementia: changes from 2000 to 2010. J Gerontol B Psychol Sci Soc Sci2018; 73: S20–S28.
11.
CrimminsEM. Social hallmarks of aging: suggestions for geroscience research. Ageing Res Rev2020; 63: 101136.
12.
SimonsRLOngMLBeachSRH, et al.Direct and indirect effects of socioeconomic status and discrimination on subjective cognitive decline: a longitudinal study of African American women. J Gerontol B Psychol Sci Soc Sci2023; 78: 799–808.
13.
RajanKBWeuveJBarnesLL, et al.Population estimate of people with clinical Alzheimer’s disease and mild cognitive impairment in the United States (2020–2060). Alzheimers Dement2021; 17: 1966–1975.
14.
MatthewsFEStephanBCMRobinsonL, et al.A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II. Nat Commun2016; 7: 11398.
15.
Dilworth-AndersonPHendrieHCManlyJJ, et al.Diagnosis and assessment of Alzheimer’s disease in diverse populations. Alzheimers Dement2008; 4: 305–309.
16.
PotterGGPlassmanBLBurkeJR, et al.Cognitive performance and informant reports in the diagnosis of cognitive impairment and dementia in African Americans and whites. Alzheimers Dement2009; 5: 445–453.
17.
CauncaMROddenMCGlymourMM, et al.Association of racial residential segregation throughout young adulthood and cognitive performance in middle-aged participants in the CARDIA Study. JAMA Neurol2020; 77: 1000–1007.
18.
BoenCEYangYCAielloAE, et al.Patterns and life course determinants of Black–white disparities in biological age acceleration: a decomposition analysis. Demography2023; 60: 1815–1841.
19.
FarinaMPKimJKCrimminsEM. Racial/ethnic differences in biological aging and their life course socioeconomic determinants: the 2016 Health and Retirement Study. J Aging Health2023; 35: 209–220.
20.
Adkins-JacksonPBKraalAZHill-JarrettTG, et al.Riding the merry-go-round of racial disparities in ADRD research. Alzheimers Dement2023; 19: 4735–4742.
21.
LamarMLernerAJJamesBD, et al.Relationship of early-life residence and educational experience to level and change in cognitive functioning: results of the Minority Aging Research Study. Gerontol B Psychol Sci Soc Sci2020; 75: e81–e92.
22.
SandoSBMelquistSCannonA, et al.Risk-reducing effect of education in Alzheimer’s disease. Int J Geriatr Psychiatry2008; 23: 1156–1162.
23.
SternYArenaza-UrquijoEMBartrés-FazD, et al.Whitepaper: defining and investigating cognitive reserve, brain reserve, and brain maintenance. Alzheimers Dement2020; 16: 1305–1311.
24.
KweonHSYunIParkJ, et al.Pubertal development, social factors, and delinquent involvement among South Korean male adolescents. Int J Law Crime Justice2017; 51: 1–13.
25.
WeuveJBennettEERankerL, et al.Exposure to air pollution in relation to risk of dementia and related outcomes: an updated systematic review of the epidemiological literature. Environ Health Perspect2022; 129: 096001.
26.
ZhangXMeirellesODLiZ, et al.Sedentary behavior, brain-derived neurotrophic factor and brain structure in midlife: a longitudinal brain MRI sub-study of the coronary artery risk development in young adults study. Front Dement2023; 2: 1110553.
27.
ShimizuYSawadaNIhiraH, et al.Alcohol consumption from midlife and risk of disabling dementia in a large population-based cohort study in Japan. Int J Geriatr Psychiatry2023; 38: e5896.
28.
FarinaMPSaenzJCrimminsEM. Does adding MRI and CSF-based biomarkers improve cognitive status classification based on cognitive performance questionnaires?PLoS One2023; 18: e0285220.
29.
GuYHonigLSKangMS, et al.Risk of Alzheimer’s disease is associated with longitudinal changes in plasma biomarkers in the multi-ethnic Washington Heights–Hamilton Heights–Inwood Columbia Aging Project (WHICAP) cohort. Alzheimers Dement2024; 20: 1988–1999.
30.
SimrénJLeuzyAKarikariTK, et al.The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer’s disease. Alzheimers Dement2021; 17: 1145–1156.
31.
JrJBennett DACRBlennowK, et al.NIA-AA Research framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement2018; 14: 535–562.
32.
BeydounMAWeissJBanerjeeS, et al.Race, polygenic risk and their association with incident dementia among older US adults. Brain Commun2022; 4: fcac317.
33.
SimonsRLOngMLLeiM-K, et al.Changes in loneliness, BDNF, and biological aging predict trajectories in a blood-based epigenetic measure of cortical aging: a study of older Black Americans. Genes (Basel)2023; 14: 842.
34.
FaulJDKimJKLevineME, et al.Epigenetic-based age acceleration in a representative sample of older Americans: associations with aging-related morbidity and mortality. Proc Natl Acad Sci U S A2023; 120: e2215840120.
35.
SugdenKCaspiAElliottML, et al.Association of pace of aging measured by blood-based DNA methylation with age-related cognitive impairment and dementia. Neurology2022; 99: e1402–e1413.
36.
O’SheaDMMaynardTTremontG. DNA Methylation ‘GrimAge’ acceleration mediates sex/gender differences in verbal memory and processing speed: findings from the Health and Retirement Study. J Gerontol A Biol Sci Med Sci2022; 77: 2402–2412.
37.
Avila-RiegerJTurneyICVonkJMJ, et al.Socioeconomic status, biological aging, and memory in a diverse national sample of older US men and women. Neurology2022; 99: e2114–e2124.
38.
GuoTZhangDZengY, et al.Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease. Mol Neurodegener2020; 15: 40.
39.
GuoLLiXGouldT, et al.T cell aging and Alzheimer’s disease. Front Immunol2023; 14: 1154699.
40.
LombardiGPaganelliRAbateM, et al.Leukocyte-derived ratios are associated with late-life any type dementia: a cross-sectional analysis of the Mugello study. GeroScience2021; 43: 2785–2793.
41.
StockerHTraresKBeyerL, et al.Alzheimer’s polygenic risk scores, APOE, Alzheimer’s disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years. Alzheimers Res Ther2023; 15: 129.
BrandtJSpencerMFolsteinM. The telephone interview for cognitive status. Neuropsychiatry Neuropsychol Behav Neurol1988; 1: 111–117.
44.
CrimminsEMKimJKLangaKM, et al.Assessment of cognition using surveys and neuropsychological assessment: the Health and Retirement Study and the Aging, Demographics, and Memory Study. J Gerontol B Psychol Sci Soc Sci2011; 66B: i162–i171.
45.
WuBToseefMUTarrafW, et al.Longitudinal daily living limitations and cognitive status: results from the 1998-2016 Health and Retirement Study. Innov Aging2020; 4: 897.
46.
StoneKLZhongJLyuC, et al.Does incident cardiovascular disease lead to greater odds of functional and cognitive impairment? Insights from the Health and Retirement Study. J Gerontol A Biol Sci Med Sci2023; 78: 1179–1188.
47.
GarciaMATarrafWReyesAM, et al.Gender, age of migration, and cognitive life expectancies among older Latinos: evidence from the Health and Retirement Study. J Gerontol Ser B2022; 77: e226–e233.
ChenTGuestrinC. XGBoost: a scalable tree boosting system. In: Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, pp.785–794.
van BuurenSGroothuis-OudshoornK. Mice: multivariate imputation by chained equations in R. J Stat Softw2011; 45: 1–67.
53.
HastieTTibshiraniRFriedmanJ. The Elements of Statistical Learning: Data Mining, Inference, and Prediction, Second Edition. 2nd edition. New York, NY: Springer, 2016.
54.
ElithJLeathwickJRHastieT. A working guide to boosted regression trees. J Anim Ecol2008; 77: 802–813.
VabalasAHartonenTVartiainenP, et al.Deep learning-based prediction of one-year mortality in Finland is an accurate but unfair aging marker. Nat Aging2024; 4: 1014–1027.
62.
BelskyDWMoffittTECohenAA, et al.Eleven telomere, epigenetic clock, and biomarker-composite quantifications of biological aging: do they measure the same thing?Am J Epidemiol2018; 187: 1220–1230.
63.
TejeraCHWareEBKobayashiLC, et al.Decomposing interaction and mediating effects of race/ethnicity and circulating blood levels of cystatin C on cognitive status in the United States health and retirement study. Front Hum Neurosci2023; 17: 1052435.
64.
FarinaMPKimJKHaywardMD, et al.Links between inflammation and immune functioning with cognitive status among older Americans in the health and retirement study. Brain Behav Immun Health2022; 26: 100559.
65.
DonahuePTXueQ-LCarlsonMC. Peak expiratory flow predicts incident dementia in a representative sample of U.S. older adults: the National Health and Aging Trends Study (NHATS). J Gerontol A Biol Sci Med Sci2023; 78: 1427–1435.
66.
WahlDAndersonRMLe CouteurDG. Antiaging therapies, cognitive impairment, and dementia. J Gerontol A Biol Sci Med Sci2020; 75: 1643–1652.
67.
CrimminsEMThyagarajanBLevineME, et al.Associations of age, sex, race/ethnicity, and education with 13 epigenetic clocks in a nationally representative U.S. sample: the Health and Retirement Study. J Gerontol A Biol Sci Med Sci2021; 76: 1117–1123.
68.
WalshSJRauLM. Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States. Am J Public Health2000; 90: 1463–1466.
69.
ChinALNegashSHamiltonR. Diversity and disparity in dementia: the impact of ethnoracial differences in Alzheimer disease. Alzheimer Dis Assoc Disord2011; 25: 187–195.
70.
FeigenbaumJJMullerCWrigley-FieldE. Regional and racial inequality in infectious disease mortality in U.S. cities, 1900–1948. Demography2019; 56: 1371–1388.
71.
LövdénMFratiglioniLGlymourMM, et al.Education and cognitive functioning across the life span. Psychol Sci Public Interest2020; 21: 6–41.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
